Skip to main content

Search

Reset all filters
83 Result(s)
Sort by

Pioneering New Medicines Through External Innovation

Pioneering New Medicines Through External Innovation

On 22 November 2024 Boehringer Ingelheim hosted the event “Unleashing Innovation at Boehringer Ingelheim: Pioneering New Medicines Through External Innovation”  at the Institute of Molecular Pathology (IMP)
Our innovation strategy

Our innovation strategy

Our Innovation Strategy at Boehringer Ingelheim in Research and Development
Open Innovation Boehringer Ingelheim

Open Innovation Boehringer Ingelheim

Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Unleashing Innovation at Boehringer Ingelheim

Unleashing Innovation at Boehringer Ingelheim

Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Innovation in Oncology and Cancer Immunology Research

Innovation in Oncology and Cancer Immunology Research

We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Science & Innovation

Science & Innovation

We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Human Health Innovation

Human Health Innovation

Boehringer Ingelheim focuses its research activities on disease areas with a high unmet medical need.
Partnering

Partnering

We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy.
Innovation through Collaboration

Innovation through Collaboration

Pharmaceutical manufacturers and healthcare professionals regularly interact to learn from each other and improve patient care.
Testing New Treatments for NF1

Testing New Treatments for NF1

The Medical University of Vienna and Boehringer Ingelheim have taken an innovative approach to the development of ways of treating NF1-associated tumors.
Reimagining digital healthcare worldwide

Reimagining digital healthcare worldwide

How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
Research Beyond Borders

Research Beyond Borders

Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.